Navigating Glucagon-Like Peptide Receptor Agonist Reinitiation Amid Access Barriers: An Adverse Drug Event Case Report [0.03%]
克服障碍重新开始使用胰高血糖素样肽受体激动剂的病例报告
Olivia Denny,Jeffrey Baron,Nicole P Albanese
Olivia Denny
Background: The expanding roles and popularity of glucagon-like peptide-1 (GLP-1) and GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists has created access barriers to medication use. We sought to describe an adverse...
Diabetes Care in A Safety Net Hospital: Impact of a Pharmacist Transitional Care Service [0.03%]
药剂师过渡期护理服务对安全网医院糖尿病照护的影响
Shanelle M Murray,Laura M Traynor,Larissa R Gabler et al.
Shanelle M Murray et al.
Background: Diabetes is associated with increased risk of hospital readmission and imposes a significant economic burden on patients and healthcare systems. Literature suggests that pharmacist-led transitions-of-care (TOC...
The Use of Intraperitoneal Ampicillin in a Patient With Enterococcus faecalis Peritonitis [0.03%]
肠球菌腹膜炎病例的腹腔注射氨苄西林治疗体验
Natalie Greer,Joanna Q Hudson,Anna Jacobs et al.
Natalie Greer et al.
Introduction: Peritoneal dialysis (PD) - associated peritonitis is a serious complication of peritoneal dialysis (PD). The 2022 International Society of Peritoneal Dialysis (ISPD) guidelines do not recommend intraperitone...
Evaluation of ChatGPT as a Tool for Answering Clinical Questions in Pharmacy Practice [0.03%]
评估ChatGPT作为药学实践中回答临床问题的工具的效果
Faria Munir,Anna Gehres,David Wai et al.
Faria Munir et al.
Background: In the healthcare field, there has been a growing interest in using artificial intelligence (AI)-powered tools to assist healthcare professionals, including pharmacists, in their daily tasks. Objectives: To provide commentary an...
Breaking the Cycle of Recurrent Clostridioides difficile Infections: A Narrative Review Exploring Current and Novel Therapeutic Strategies [0.03%]
艰难梭菌感染的复发：当前及新型治疗策略的叙事性综述
Shelbye R Herbin,Hannah Crum,Krista Gens
Shelbye R Herbin
Clostridioides difficile is a toxin-producing bacteria that is a main cause of antibiotic-associated diarrhea. Clostridioides difficile infections (CDI) are associated with disruptions within the gastrointestinal (GI) microbiota which can b...
Impact of GLP-1 Receptor Agonist Use in Patients With Steatotic Liver Disease and Type 2 Diabetes: A Retrospective Cohort Study [0.03%]
GLP-1受体激动剂在糖尿病伴脂肪肝患者中的应用效果：回顾性队列研究
Marci Wood,Amanda G Kennedy,Sidra Khan et al.
Marci Wood et al.
Background: Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) help manage type 2 diabetes (T2DM) and may have efficacy in steatotic liver disease. Objective: To determine the prevalence and clinical impact of GLP-1 RA use in patients wi...
Briefing on Investigational Chimeric Antigen Receptor T-Cell Immunotherapies in Pediatric Neoplasms [0.03%]
儿科肿瘤调查性嵌合抗原受体T细胞免疫疗法简报
Brielle Stawicki,Tyler Schacher,Anna Dushenkov et al.
Brielle Stawicki et al.
The promising results seen in the treatment of refractory hematologic malignancies with tisagenlecleucel (Kymriah), the pioneering Chimeric Antigen Receptor (CAR) T-cell immunotherapy, has stimulated a fast growth in research and clinical t...
Samantha J Leatham,Karl R Winckel,Keshia R De Guzman
Samantha J Leatham
Background: Peripheral arterial disease (PAD) is a complex, heterogeneous condition that has become a leading health concern globally. Peripheral arterial disease often co-exists with other vascular disease states, including cerebrovascular...
Increasing Naloxone Access and Prescribing for Patients on High-Dose Opioids From a Managed Care Pharmacy Health Plan Perspective [0.03%]
从药品福利管理计划的角度增加对高剂量阿片类药物使用者的纳洛昔酮的获取和处方
Jodi P Hansgen,Megan L Robertson,Ellen M Verzino et al.
Jodi P Hansgen et al.
Background: Opioid overdoses decrease when communities have access to naloxone. Clinicians play a key role in offering naloxone to high-risk chronic opioid patients. Managed care pharmacists within our health plan noted disproportionate pro...
Evaluation of Tacrolimus Concentrations and Clinical Outcomes Between Extended and Immediate Release Formulations in Kidney Transplant [0.03%]
评价肾脏移植受者中 tacrolimus 控释剂和立释剂血药浓度及临床疗效的比较研究
Hannah Naguib,Goni Katz-Greenberg,Matt Harris et al.
Hannah Naguib et al.
Objectives: Tacrolimus remains the mainstay of immunosuppression in kidney transplantation. Understanding the relationship between therapeutic tacrolimus levels and outcomes of acute rejection, patient/graft survival, and tolerability are i...